The pharmaceutical company AstraZeneca has announced that the vaccine against the coronavirus (COVID-19), which it developed together with researchers at the University of Oxford, has a new name - Vaxzevria. From now on, it will be indicated in the vaccine's summary of characteristics, package leaflet, vaccination records and other documents, the Ministry of Health (SAM) said in a statement.
After the European Medicines Agency (EMA) evaluated the clinical trial data of this vaccine and recommended its use for vaccination against COVID-19, Vaxzevria on January 29. was registered throughout the European Union. The supply of the vaccine to Lithuania began on February 6.
Since then, AstraZeneca has delivered 127,7 thousand to Lithuania. of vaccine doses, and 106,4 thousand have already been used for vaccination of the population. doses.
